key: cord-0773085-au32486p authors: Esnault, Pierre; Cardinale, Michael; Hraiech, Sami; Goutorbe, Philippe; Baumstrack, Karine; Prud’homme, Eloi; Bordes, Julien; Forel, Jean-Marie; Meaudre, Eric; Papazian, Laurent; Guervilly, Christophe title: High Respiratory Drive and Excessive Respiratory Efforts Predict Relapse of Respiratory Failure in Critically Ill Patients with COVID-19 date: 2020-10-15 journal: Am J Respir Crit Care Med DOI: 10.1164/rccm.202005-1582le sha: 251137f61f318df8ee5428f710e17dc1e6251aa4 doc_id: 773085 cord_uid: au32486p nan around the world (1) . This infection often requires ICU admissions and invasive mechanical ventilation (2) . To prevent diaphragmatic atrophy and to enhance weaning, the early use of ventilatory modes allowing spontaneous breathing is usually recommended as soon as possible but should be balanced with potential harmful effects. Indeed, a high respiratory drive is sometimes observed in patients with acute respiratory distress syndrome (ARDS), and thus, spontaneous breathing could lead to uncontrolled transpulmonary pressures and possibly to patient self-inflicted lung injuries (P-SILI) (3, 4) . Strong efforts could also simply reflect the nonresolution of the underlying disease and thus invite to delay the weaning process of mechanical ventilation. Lacking specific respiratory monitoring, surrogate measures of respiratory drive should be assessed. Airway occlusion pressure (P 0.1 ) is a simple, noninvasive measurement method for estimating respiratory drive during mechanical ventilation (3, 5) . It is automatically available in almost all ventilators. P 0.1 is the negative airway pressure generated during the first 100 ms of an occluded inspiration. Because of the very short duration and zero flow, it is independent from respiratory muscle weakness as well as respiratory system compliance and resistance. However, it provides little information about the magnitude of dynamic lung stress (5, 6) . It has been proposed to target a range between 1.5 and 3.5 cm H 2 O of P 0.1 (3) . The airway pressure deflection generated by the patient's respiratory effort during an endexpiratory airway occlusion (DPocc) is a recently validated noninvasive technique for detecting excessive respiratory effort and dynamic lung stress during assisted mechanical ventilation (6) . Bertoni and colleagues showed that measurements of DPocc allow a reliable and bedside estimation of respiratory muscle pressure (Pmus) by using a conversion factor (predicted Pmus = 20.75 3 DPocc) (6) . Besides, in a recent editorial, Gattinoni and colleagues suggested that P 0.1 and DPocc should be determined in patients with COVID-19 to assess excessive inspiratory efforts (7) . The validity of P 0.1 or DPocc measurements in intubated and mechanically ventilated patients with COVID-19 has not been evaluated. We hypothesized that mechanically ventilated patients with COVID-19 with ARDS often present high respiratory drive and excessive inspiratory efforts (as suggested by elevated P 0.1 and DPocc measurements) and that this could rapidly lead to a relapse of respiratory failure during the weaning process of mechanical ventilation. Therefore, the aim of this study was to assess the threshold values of P 0.1 and DPocc predicting the occurrence of relapse in the following 24-hour period after measurements in intubated and mechanically ventilated patients with COVID-19 pneumonia. We conducted a retrospective, bicenter study at the Sainte Anne Military Hospital and the Marseille University North Hospital. This study enrolled critically ill patients with mild to severe ARDS due to COVID-19 (positive result of a real-time RT-PCR assay in nasal or pulmonary samples), intubated and mechanically ventilated, in supine position, and with spontaneous breathing (pressure support ventilation [PSV] or airway pressure release ventilation [APRV]). The study was approved by the institutional review board of the Sainte Anne Military Hospital (no. 0011873-2020-05), which waived the requirement for informed consent from patients and their relatives, given the retrospective and observational nature of the study. P 0.1 and DPocc measurements were performed by the clinician in charge in each patient on the first day on APRV mode or PSV mode. P 0.1 was measured at least three times (1 min between each measurement), and the mean P 0.1 was notified. DPocc was defined as the maximal deflection in airway pressure from positive end-expiratory pressure (PEEP) during an endexpiratory airway occlusion (6) . Measurements were repeated at least three times, and the highest value was recorded. Automated measurements were performed with four commercialized ventilators: Evita XL (Dräger), Evita Infinity V500 (Dräger), Avea (CareFusion), and Carescape R860 (GE Healthcare). The accuracy and precision of values of P 0.1 displayed by these ventilators have been validated (8, 9) . The same ventilator was used for a given patient. The main endpoint of the study was a relapse of respiratory failure during the weaning process of invasive mechanical ventilation in the 24-hour period following measurements defined by the presence of at least one of the (10) . If temporary deoxygenations were observed (e.g., following an accidental ventilator disconnection, airway suctioning, transport to computed tomographic scan) and were not followed by any medical intervention (i.e., change of ventilator settings, increase in sedations), they were not considered a relapse of respiratory failure. The method of weaning was similar in the two ICUs. Briefly, all patients were initially ventilated in volume-controlled mode. When the Pa O 2 /FI O 2 ratio was greater than 150 mm Hg during at least 6 hours without neuromuscular blockers, and/or use of prone positioning or inhaled nitric oxide in the last 12 hours, volume-controlled mode was switched to APRV mode (minimal time high :time low was 1 s:1.5-2 s, Phigh was set to achieve a VT of 6-8 ml/kg of PBW with a maximal driving pressure of 15 cm H 2 O, Plow was the corresponding PEEP during volume-controlled mode). When spontaneous minute ventilation was above 50% in APRV mode, ventilator settings were switched to PSV. The PS was then decreased every 4 hours if VT remained >6 ml/kg of PBW and respiratory rate remained ,35/min. PEEP was gently ( Statistical analysis was performed using R software, version 3.5.1 (The R Foundation for Statistical Computing). Nonparametric variables were compared using a Mann-Whitney test. Abilities of P 0.1 or DPocc to predict a relapse of respiratory failure were represented by a receiver operating characteristic (ROC) curve analysis. Areas under the curves (AUCs) were presented with their 95% confidence interval (95% CI). The diagnostic cutoff was determined by the highest Youden index value. Because some patients underwent several P 0.1 and DPocc measurements, we analyzed only the first values of P 0.1 and DPocc measurements. Twenty-eight patients with COVID-19 admitted in the two ICUs from March 10 through April 14, 2020, were included. Population characteristics are displayed in Table 1 . A total of 28 paired measurements of P 0.1 (3 measures, mean value of the 3) and DPocc (highest value of 3 measures) were performed (4 on APRV mode and 24 on PSV mode). Time from the onset of invasive mechanical ventilation to first measurements was 8.5 (interquartile range [IQR], 4-12) days. Before measurements, median Richmond Agitation-Sedation Scale was 24 (IQR, 24 to 24). Ventilator settings before measurements were as follows: PS at 6 (IQR, 4-11) cm H 2 O, PEEP at 12 (IQR, 10-14) cm H 2 O, and VT of 6.6 (IQR, 6.3-7.3) ml/kg of PBW. Median rapid shallow breathing index was 49 (IQR, 40-62) breaths/min/L. Median minute ventilation was 11.1 (IQR, 8.9-12.6) L/min. Results of last blood gas analysis before measurements were as follows: Pa O 2 83 (IQR, 77-97) mm Hg, Pa CO Of the 28 measurements, 9 (32%) were followed by a relapse of respiratory failure. As illustrated in the Figure 1 , median P 0.1 were significantly higher in those cases ( One measurement was followed by a successful extubation with a value of P 0.1 at 3.0 cm H 2 O. ROC curve showed that P 0.1 had a satisfactory accuracy to predict a relapse with an AUC of 0.84 (95% CI, 0.67-1.00), P = 0.004 ( Figure 1 ). The maximum value of the Youden index was obtained for a P 0.1 >4 cm H 2 O. The prognostic performance of this threshold showed a sensitivity of 89% (95% CI, 52-100), a specificity of 74% (95% CI, 49-91), a positive predictive value of 62% (95% CI, 32-86), a negative predictive value of 93% (95% CI, 68-100), a positive likelihood ratio (LR) of 3.38 (95% CI, 1.54-7.42), a negative LR of 0.15 (95% CI, 0.02-0.98), and a diagnostic accuracy of 79% (95% CI, 59-92). ROC curve demonstrated that DPocc had an acceptable accuracy to predict a relapse with an AUC of 0.73 (95% CI, 0.55-0.92), P = 0.05 ( Figure 1 ). The maximum value of the Youden index was obtained for a DPocc , 210 cm H 2 O. The prognostic performance of this threshold showed a sensitivity of 100% (95% CI, 66-100), a specificity of 42% (95% CI, 20-67), a positive predictive value of 45% (95% CI, 23-68), a negative predictive value of 100% (95% CI, 63-100), a positive LR of 1.73 (95% CI, 1.18-2.53), a negative LR of 0.00 (95% CI, 0.00-0.00), and a diagnostic accuracy of 61% (95% CI, 41-78). Prognostic performances of the other thresholds are presented in Table 2 . Finally, AUC for P 0.1 was not significantly different than AUC for DPocc (DeLong's test, P = 0.32). We then split measurements into four categories: low DPocc (>215 cm H 2 O)/low P 0.1 (,4 cm H 2 O), high DPocc (,215 cm H 2 O)/low P 0.1 , low DPocc/high P 0.1 (>4 cm H 2 O), and high DPocc/high P 0.1 . Proportions of relapse of respiratory failure were, respectively, 0/11 (0%), 1/4 (25%), 3/5 (60%), and 5/8 (62.5%) (P = 0.015). In this cohort of patients with COVID-19, we found that P 0.1 was frequently above 3.5 cm H 2 O, suggesting high neural respiratory drive (3, 11) . Even if ranges of P 0.1 up to 6.0 cm H 2 O have been reported in patients with ARDS, a quarter of our measurements were above this value (5). P 0.1 is an easy and reliable tool to measure the respiratory drive, available worldwide. Recently, Telias and colleagues demonstrated that P 0.1 directly displayed by the ventilator correlates with invasive measures of respiratory drive (electrical activity of the diaphragm and muscular pressure measured with esophageal pressure). They also showed that P 0.1 was well correlated with pressure-time product per minute, a surrogate of inspiratory effort (9). We found that P 0.1 had a reliable accuracy to predict relapse of respiratory failure in the first 24 hours after measurement of P 0.1 and DPocc in our population. A P 0.1 >4.0 cm H 2 O had an excellent specificity and negative predictive value. Relapse might be a consequence of P-SILI and myotrauma, or also due to the nonresolution of the COVID-19 pneumonia. High drive and excessive respiratory efforts could possibly lead to P-SILI through different mechanisms such as an excessive global and regional lung stress, a pulmonary edema, or patient-ventilator asynchronies (3). The diaphragm is also sensitive to an excessive respiratory load, ensuing load-induced diaphragm injury (myotrauma). DPocc measurements were also frequently less than 215 cm H 2 O, which can correspond, after application of conversion factor, to Pmus greater than 10 cm H 2 O, indicating excessive respiratory efforts (6) . Indeed, Bertoni and colleagues propose to target a range of Pmus between 5 and 10 cm H 2 O during spontaneous breathing (3) . Even if DPocc was less discriminating than P 0.1 , its regular measurement is also interesting to predict a relapse of respiratory failure during mechanical ventilation weaning. Moreover, we found that high DPocc and high P 0.1 association is at higher risk of relapse of respiratory failure. This study has several limitations including its retrospective design and the limited number of patients included. A comparative measure of respiratory drive and inspiratory efforts such as electrical activity of the diaphragm or muscular pressure measured with esophageal catheter might have helped to confirm our results. In conclusion, in this COVID-19 pandemic context, with limited time and material resources, serial measurements of P 0.1 and DPocc could be a valuable bedside clinical tool to predict relapse of respiratory failure in the next 24 hours and therefore to potentially delay the weaning process of mechanical ventilation, especially when P 0.1 is >4 cm H 2 O and DPocc is ,215 cm H 2 O. n To the Editor: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the so-called coronavirus disease (COVID-19), which is characterized by a broad spectrum of clinical presentations ranging from asymptomatic patients to critically ill individuals with a high case fatality rate (1). The critical care community has increasingly recognized that cardiovascular and thrombotic complications are relatively common in COVID-19 (2) . Indeed, direct involvement of the vascular endothelium was recently reported in a series of patients suffering from severe COVID-19 (3). The endothelial glycocalyx (eGC), which covers the luminal surface of endothelial cells, contributes to the maintenance of vascular homeostasis, whereas disruption of the eGC is observed early in critically ill patients and is associated with inferior outcomes (4, 5) . Here, we investigated in translational human and cellular studies whether injury to the eGC can be found in critically ill patients with COVID-19 early after admission to the ICU. We collected plasma and serum from 19 adult individuals within 24 hours after invasive ventilation for acute respiratory distress syndrome and from 10 healthy human donors after written informed consent of patients or their legal representative. The first patient was admitted on March 19, 2020, and the observation period was until May 17, 2020. The median (interquartile range) observation duration was 47 (40-54) days. Baseline patient characteristics at study inclusion as well as a description of the further clinical course are summarized in Table 1 . Organ failure was not restricted to the lungs, and multiorgan dysfunction was common both at inclusion and during the further clinical course. Surprisingly, global markers of endothelial injury such as Angpt- Figure 1A ) and in syndecan-1 ( Figure 1B )indicating pathological shedding of transmembrane proteins involved in glycocalyx structure and processing-were observed. The key eGC sheddase Hpa-1 (heparanase-1) and its enzymatic activity were both not significantly increased (data not shown). To the contrary, the Hpa-1 counterpart, the protective Hpa-2 (heparanase-2), was pertinently reduced in all patients with COVID-19 ( Figure 1C ). Driven by this acquired Hpa-2 deficiency, the Hpa-1:Hpa-2 ratio was higher in patients with COVID-19 (P = 0.012; data not shown). Together, this indicates that critically ill patients with COVID-19 suffer from an acquired Hpa-2 deficiency that can contribute to the degradation of the eGC, maybe even before classical endothelial activation and injury. Next, eGC structure was analyzed in humans, employing sublingual sidestream darkfield (SDF) imaging. We quantified the size of the individual patients' eGC using an indirect surrogate termed the perfused boundary region and found a decrease of perfused boundary region, indicating reduced eGC thickness in patients with COVID-19. To demonstrate that the deficiency of Hpa-2 is mechanistically involved in the degradation of the eGC, we used a microfluidic chamber with cultured endothelial cells (ECs) under flow that synthesize an intact and stable eGC under in vitro conditions. After stimulation with COVID-19 or control serum, the eGC was visualized by confocal microscopy followed by computerized three-dimensional reconstruction. Its thickness was then quantified by analyzing the heparan sulfate (HS)-positive area. We found that stimulation with COVID-19 was sufficient to severely damage the eGC ( Figure 1E ). The HS-positive area was reduced by 34% (control: 6.1 6 0.9% vs. COVID-19: 4 6 0.4% P , 0.001). Consistent with our observation in patients, we found that the transcription of Hpa-2 in COVID-19-stimulated ECs was significantly reduced after 6 hours (0.63 6 0.02 relative expression to control; P = 0.003). Of note, transgenic overexpression of Hpa-2 in a lentivirus-transduced EC line was sufficient to reverse this phenotype, as the HS area in COVID-19 serum-treated lenti-control cells was 1.9 6 0.6% but was 4.2 6 1.2% in lenti-Hpa-2-overexpressing cells (P , 0.001). In other words, if ECs overexpress Hpa-2, the serum of patients with COVID-19 cannot degrade the eGC anymore. This exploratory study has obvious limitations, most importantly, its small sample size and hypothesis-generating nature. Injury to the eGC is not a finding specific for COVID-19 but can be found in a wide range of critically ill patients (5) . Because only a small selection of molecules that may participate in endothelial injury have been investigated in this study, we cannot exclude that further mediators may play a critical role in endothelial and eGC injury in patients with COVID-19. In addition, because of concerns of viral transmission, SDF imaging values could not be obtained from the same control patients from whom blood analysis was performed but were obtained from a separate historic in-center control cohort. Both control cohorts were not matched to the individual patients in terms of age, but the control group that blood was collected from was matched in terms of male predominance. In summary, we found injury of the eGC and speculate that this might represent a potentially critical hallmark of later widespread endothelial injury in severe COVID-19. Reduced eGC thickness was visualized in vivo by employing sublingual SDF imaging in patients. At the same time, increased syndecan-1 and sTie-2 concentrations in the blood of these patients indicated shedding of important Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America COVID-19 associated pulmonary aspergillosis COVID-19-associated pulmonary aspergillosis High prevalence of putative invasive pulmonary aspergillosis in critically ill COVID-19 patients. SSRN Electron J [online ahead of print Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia COVID-19-associated invasive pulmonary aspergillosis Diagnosing COVID-19-associated pulmonary aspergillosis AspICU Study Investigators. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients A novel coronavirus from patients with pneumonia in China COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region Monitoring patient respiratory effort during mechanical ventilation: lung and diaphragm-protective ventilation Mechanical ventilation to minimize progression of lung injury in acute respiratory failure The airway occlusion pressure (P 0.1 ) to monitor respiratory drive during mechanical ventilation: increasing awareness of a not-so-new problem A novel non-invasive method to detect excessively high respiratory effort and dynamic transpulmonary driving pressure during mechanical ventilation COVID-19 pneumonia: different respiratory treatments for different phenotypes? Accuracy of P0.1 measurements performed by ICU ventilators: a bench study Airway occlusion pressure as an estimate of respiratory drive and inspiratory effort during assisted ventilation Pathophysiology and management of acute respiratory distress syndrome in obese patients